Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Nov
26
2013
Exhausting Patent Rights Without a Sale McDermott Will & Emery
Nov
26
2013
Patent Rights in Renewable Energy Government Contracts: The Basics Lewis Roca Rothgerber LLP
Nov
26
2013
Prosecution History Estoppel Presumptively Applies to Narrowing Claim Amendments McDermott Will & Emery
Nov
25
2013
Apple, Inc. v. Samsung Electronics Co., Ltd.: Appellate Court Decision Sets Stage for Next Skirmish in the Smart Phone Wars McDermott Will & Emery
Nov
25
2013
Federal Trade Commission (FTC) Focuses Enforcement Efforts on Health Care, Technology and Energy Sectors McDermott Will & Emery
Nov
25
2013
Restriction Practice Regarding 35 USC §121 Womble Bond Dickinson (US) LLP
Nov
22
2013
Georgia Knife Companies Cross Swords in Complaints by Bud K and United Cutlery Alleging Copyright and Trademark Infringement Against Mutual Competitor Wholesale Gallery Womble Bond Dickinson (US) LLP
Nov
21
2013
Divisional Practice in the BRICs (Brazil, Russia, India and China) and other Countries – Part 2 of a 9-Part Series Michael Best & Friedrich LLP
Nov
19
2013
Copyright Owners: Keep Your Eye on the Road Bracewell LLP
Nov
19
2013
Chinese Acquisition of US Technology: Export Regulation and Foreign Investment Issue Spotting Sheppard, Mullin, Richter & Hampton LLP
Nov
19
2013
Appellate Decision Sets Stage for Next Skirmish in the Apple vs. Samsung Smartphone Wars McDermott Will & Emery
Nov
19
2013
Federal Trade Commission (FTC) Broadens Notification Requirements for Transfers of Pharmaceutical Patent Rights Bracewell LLP
Nov
18
2013
Ohio Willow Wood Co. v. Alps South, LLC – Inequitable Conduct Lives! Schwegman, Lundberg & Woessner, P.A.
Nov
18
2013
No Avoiding BPCIA (Biologics Price Competition and Innovation Act) For Biosimilars: No Patent Declaratory Judgment Action Before Biosimilars Application Is Filed Sheppard, Mullin, Richter & Hampton LLP
Nov
18
2013
Pay-for-delay to Stay FTC’s (Federal Trade Commission) Top Priority McDermott Will & Emery
Nov
18
2013
Heartburn for Drug Manufacturers: "Reverse Payment" That Did Not Include a Monetary Payment Held Actionable Under the Antitrust Laws Greenberg Traurig, LLP
Nov
18
2013
Is This Patentable? Lewis Roca Rothgerber LLP
Nov
17
2013
Final Rules Adopted, Making More Pharmaceutical Patent Transfers Subject to the HSR (Hart-Scott-Rodino) Act: Increased Review Raises Importance of Valuation Greenberg Traurig, LLP
Nov
15
2013
Patent Eligible Subject Matter: A Review of What Others Are Saying Womble Bond Dickinson (US) LLP
Nov
14
2013
Expanded HSR Rules Require Reporting of Pharmaceutical Patent Exclusive Licenses, All Exclusive Deals Called "Potentially Reportable" By FTC ArentFox Schiff LLP
Nov
14
2013
Patent Mediation [VIDEO] Mintz
Nov
13
2013
Divisional Practice in the BRICs (Brazil, Russia, India and China) and other Countries – Part 1 of a 9-Part Series Michael Best & Friedrich LLP
Nov
11
2013
Ariosa Diagnostics v. Sequenom: Another One Bites The Dust Schwegman, Lundberg & Woessner, P.A.
Nov
11
2013
New Hart-Scott-Rodino (HSR) Rules Will Require More Filings for Pharmaceutical Patent Transfers: Increased Review Raises Importance of Valuation Greenberg Traurig, LLP
Nov
10
2013
Titanic Lawsuit Proceeds after Dismissal of Overseas Defendants Based on Rejection of Reverse Alter Ego Theory Womble Bond Dickinson (US) LLP
Nov
10
2013
Eastern District of Texas Adopts Limits on Asserted Patent Claims and Prior Art Morgan, Lewis & Bockius LLP
Nov
9
2013
Copyright Matters [VIDEO] Mintz
Nov
8
2013
What Makes a Great Patent? [VIDEO] Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins